These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37767604)

  • 21. Reactivation of Epstein-Barr virus in Sjögren's syndrome.
    Fox RI; Howell FV
    Ric Clin Lab; 1987; 17(4):273-7. PubMed ID: 2830658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microflora in oral ecosystems in primary Sjögren's syndrome.
    Almståhl A; Wikström M; Kroneld U
    J Rheumatol; 2001 May; 28(5):1007-13. PubMed ID: 11361180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supra-gingival microbiota in Sjögren's syndrome.
    Leung KC; Leung WK; McMillan AS
    Clin Oral Investig; 2007 Dec; 11(4):415-23. PubMed ID: 17609998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing Microbiota from Sjögren's Syndrome Patients.
    Singh M; Teles F; Uzel NG; Papas A
    JDR Clin Trans Res; 2021 Jul; 6(3):324-332. PubMed ID: 32689841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions.
    Tsigalou C; Stavropoulou E; Bezirtzoglou E
    Front Immunol; 2018; 9():1106. PubMed ID: 29881381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome.
    Rhodus NL; Bloomquist C; Liljemark W; Bereuter J
    J Otolaryngol; 1997 Oct; 26(5):300-5. PubMed ID: 9343767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deterioration in saliva quality in patients with Sjögren's syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations.
    Azuma N; Katada Y; Sano H
    Inflamm Regen; 2018; 38():6. PubMed ID: 29657585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of aquaporin 5 in Sjögren's syndrome.
    Chivasso C; D'Agostino C; Parisis D; Soyfoo MS; Delporte C
    Autoimmun Rev; 2023 Mar; 22(3):103268. PubMed ID: 36621535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral manifestations and their treatment in Sjögren's syndrome.
    González S; Sung H; Sepúlveda D; González M; Molina C
    Oral Dis; 2014 Mar; 20(2):153-61. PubMed ID: 23557026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune complexome analysis reveals the presence of immune complexes and identifies disease-specific immune complex antigens in saliva samples from patients with Sjögren's syndrome.
    Yamane K; Nakamura H; Hamasaki M; Minei Y; Aibara N; Shimizu T; Kawakami A; Nakashima M; Kuroda N; Ohyama K
    Clin Exp Immunol; 2021 May; 204(2):212-220. PubMed ID: 33432580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin β
    Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
    Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of Sjögren's syndrome].
    Bierc J; Borzym K; Waszkiel D; Daniszewska I; Zalewska A
    Wiad Lek; 2014; 67(4):520-7. PubMed ID: 26030959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
    Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
    Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral microbial flora in Sjögren's syndrome.
    Almståhl A; Kroneld U; Tarkowski A; Wikström M
    J Rheumatol; 1999 Jan; 26(1):110-4. PubMed ID: 9918250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
    Riega-Torres JC; Villarreal-Gonzalez AJ; Ceceñas-Falcon LÁ; Salas-Alanis JC
    Gac Med Mex; 2016; 152(3):371-80. PubMed ID: 27335194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
    Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
    Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A spatial gradient of bacterial diversity in the human oral cavity shaped by salivary flow.
    Proctor DM; Fukuyama JA; Loomer PM; Armitage GC; Lee SA; Davis NM; Ryder MI; Holmes SP; Relman DA
    Nat Commun; 2018 Feb; 9(1):681. PubMed ID: 29445174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren's syndrome-like phenotype in mice.
    Nakamura H; Tanaka T; Pranzatelli T; Ji Y; Yin H; Perez P; Afione SA; Jang SI; Goldsmith C; Zheng CY; Swaim WD; Warner BM; Hirata N; Noguchi M; Atsumi T; Chiorini JA
    Ann Rheum Dis; 2021 Aug; 80(8):1031-1039. PubMed ID: 33658234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.